Dermira Shares Outstanding 2013-2018 | DERM

Dermira shares outstanding history from 2013 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Dermira shares outstanding for the quarter ending June 30, 2018 were 0.042B, a 0.89% increase year-over-year.
  • Dermira 2017 shares outstanding were 0.041B, a 22.75% increase from 2016.
  • Dermira 2016 shares outstanding were 0.033B, a 23.64% increase from 2015.
  • Dermira 2015 shares outstanding were 0.027B, a 315.92% increase from 2014.
Dermira Annual Shares Outstanding
(Millions of Shares)
2017 41
2016 33
2015 27
2014 6
2013 1
2012 1
Dermira Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 42
Q1 2018 42
Q4 2017 41
Q3 2017 42
Q2 2017 42
Q1 2017 37
Q4 2016 33
Q3 2016 35
Q2 2016 31
Q1 2016 30
Q4 2015 27
Q3 2015 28
Q2 2015 25
Q1 2015 25
Q4 2014 6
Q3 2014 1
Q2 2014 1
Q1 2014 1
Q4 2013 0
Q3 2013 1
Q4 2012 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.434B $0.005B
Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.219B 11.49
Zoetis (ZTS) United States $43.282B 31.41
Grifols (GRFS) Spain $14.428B 18.70
Tilray (TLRY) United States $11.457B 0.00
Neurocrine Biosciences (NBIX) United States $10.822B 0.00
Nektar Therapeutics (NKTR) United States $10.176B 11.90
Jazz Pharmaceuticals (JAZZ) Ireland $9.894B 14.56
Impax Laboratories (AMRX) United States $7.032B 0.00
Sage Therapeutics (SAGE) United States $6.813B 0.00
Ionis Pharmaceuticals (IONS) United States $6.746B 0.00
Catalent (CTLT) United States $6.179B 26.66
United Therapeutics (UTHR) United States $5.347B 6.86
FibroGen (FGEN) United States $4.874B 0.00
Loxo Oncology (LOXO) United States $4.853B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.920B 15.18
Endo (ENDP) Ireland $3.610B 5.18
Madrigal Pharmaceuticals (MDGL) United States $3.248B 0.00
USANA Health Sciences (USNA) United States $2.892B 25.48
Aerie Pharmaceuticals (AERI) United States $2.643B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.630B 0.00
Heron Therapeutics (HRTX) United States $2.441B 0.00
Xencor (XNCR) United States $2.394B 0.00
PTC Therapeutics (PTCT) United States $2.269B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.263B 0.00
TESARO (TSRO) United States $2.070B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.069B 0.00
Portola Pharmaceuticals (PTLA) United States $1.821B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.791B 21.90
Zogenix (ZGNX) United States $1.761B 0.00
Corcept Therapeutics (CORT) United States $1.665B 25.63
Theravance Biopharma (TBPH) Cayman Islands $1.600B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.564B 0.00
Tricida (TCDA) United States $1.534B 0.00
TherapeuticsMD (TXMD) United States $1.532B 0.00
ImmunoGen (IMGN) United States $1.350B 0.00
Endocyte (ECYT) United States $1.233B 0.00
Esperion Therapeutics (ESPR) United States $1.157B 0.00
Karyopharm Therapeutics (KPTI) United States $1.110B 0.00
Radius Health (RDUS) United States $0.815B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.796B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.749B 0.00
Flexion Therapeutics (FLXN) United States $0.697B 0.00
Dova Pharmaceuticals (DOVA) United States $0.675B 0.00
ChemoCentryx (CCXI) United States $0.635B 37.97
GlycoMimetics (GLYC) United States $0.611B 0.00
Siga Technologies (SIGA) United States $0.572B 0.00
Odonate Therapeutics (ODT) United States $0.565B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.562B 0.00
OptiNose (OPTN) United States $0.559B 0.00
ArQule (ARQL) United States $0.553B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.539B 0.00
Collegium Pharmaceutical (COLL) United States $0.508B 0.00
CASI Pharmaceuticals (CASI) United States $0.494B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.474B 0.00
Akebia Therapeutics (AKBA) United States $0.472B 0.00
Minerva Neurosciences (NERV) United States $0.471B 0.00
Aclaris Therapeutics (ACRS) United States $0.470B 0.00
Majesco Entertainment (PTE) United States $0.465B 0.00
Translate Bio (TBIO) United States $0.451B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 29.11
Verrica Pharmaceuticals (VRCA) United States $0.419B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.419B 0.00
Xeris Pharmaceuticals (XERS) United States $0.418B 0.00
Forty Seven (FTSV) United States $0.411B 0.00
Aquestive Therapeutics (AQST) United States $0.407B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.398B 0.00
Zafgen (ZFGN) United States $0.397B 0.00
Mast Therapeutics (SVRA) United States $0.393B 0.00
Depomed (ASRT) United States $0.392B 0.00
ElectroCore (ECOR) United States $0.392B 0.00
KalVista Pharmaceuticals (KALV) United States $0.373B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.356B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.345B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.323B 0.00
Concert Pharmaceuticals (CNCE) United States $0.317B 0.00
MEI Pharma (MEIP) United States $0.313B 0.00
Opexa Therapeutics (ACER) United States $0.301B 0.00
Aratana Therapeutics (PETX) United States $0.284B 0.00
Affimed (AFMD) Germany $0.273B 0.00
Galectin Therapeutics (GALT) United States $0.267B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.265B 0.00
Ardelyx (ARDX) United States $0.258B 0.00
Melinta Therapeutics (MLNT) United States $0.252B 0.00
Ocular Therapeutix (OCUL) United States $0.249B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.244B 0.00
Tyme Technologies (TYME) United States $0.242B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.239B 0.00
IMV INC (IMV) Canada $0.232B 0.00
Jounce Therapeutics (JNCE) United States $0.220B 0.00
Neon Therapeutics (NTGN) United States $0.215B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.204B 0.00
Lannett Co Inc (LCI) United States $0.195B 1.61
Aldeyra Therapeutics (ALDX) United States $0.191B 0.00
Achaogen (AKAO) United States $0.190B 0.00
Calithera Biosciences (CALA) United States $0.178B 0.00
DURECT (DRRX) United States $0.173B 0.00
MediWound (MDWD) Israel $0.172B 0.00
Redhill Biopharma (RDHL) Israel $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
Immune Design (IMDZ) United States $0.169B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.161B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.154B 0.00
Adherex Technologies (FENC) United States $0.154B 0.00
Molecular Templates (MTEM) United States $0.149B 0.00
Neos Therapeutics (NEOS) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.147B 0.00
Recro Pharma (REPH) United States $0.146B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.145B 0.00
Cardiome Pharma (CORV) Canada $0.140B 0.00
ProNAi Therapeutics (SRRA) Canada $0.138B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
ContraFect (CFRX) United States $0.129B 0.00
CTI BioPharma (CTIC) United States $0.115B 0.00
Forward Pharma (FWP) Denmark $0.112B 0.00
Iterum Therapeutics (ITRM) Ireland $0.105B 0.00
BioLineRx (BLRX) Israel $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 0.00
Trillium Therapeutics (TRIL) Canada $0.087B 0.00
Nivalis Therapeutics (ALPN) United States $0.086B 0.00
Otonomy (OTIC) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.077B 8.69
KemPharm (KMPH) United States $0.072B 0.00
Novan (NOVN) United States $0.070B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.00
Mannatechorporated (MTEX) United States $0.049B 25.57
Genocea Biosciences (GNCA) United States $0.048B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.047B 0.00
Capnia (SLNO) United States $0.046B 0.00
Heat Biologics (HTBX) United States $0.045B 0.00
Onconova Therapeutics (ONTX) United States $0.042B 0.00
Avenue Therapeutics (ATXI) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
Xenetic Biosciences (XBIO) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.027B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.022B 0.00
Shineco (TYHT) China $0.022B 1.85
Cyanotech (CYAN) United States $0.020B 0.00
Aradigm (ARDM) United States $0.018B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
Intellipharmaceutics (IPCI) Canada $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Pain Therapeutics (PTIE) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
RXi Pharmaceuticals (RXII) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00